FDA Adverse Event Injury Summary report: N

ASR UNI FEMORAL IMPL SIZE 49

MDR report key: 3181215 · Received June 21, 2013

Report

Report Number
1818910-2013-03189
Event Type
Injury
Date Received
June 21, 2013
Report Date
December 2, 2011
Manufacturer
DEPUY INTERNATIONAL
Product Code
KWA
PMA / PMN Number
K040627
Removal / Correction Number
Z1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. REF. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Description of Event or Problem · 1

LITIGATION PAPERS ALLEGE: PAIN AND SUFFERING, DISABILITY, IMPAIRMENT, LOSS OF FUNCTION, USE AND RANGE OF MOTION, DECREASED AND POOR HIP PERFORMANCE AND LONGEVITY, GAIT DISTURBANCES, LOSS OF ENJOYMENT OF LIFE, EMOTIONAL DISTRESS, INCREASED LIKELIHOOD OF FUTURE COMPLICATIONS AND SURGERY, INCREASED LIKELIHOOD DISABILITY, INCREASED LIKELIHOOD OF ARTHRITIS, FEAR OF FUTURE COMPLICATIONS AND SURGERY, METALLIC AND OTHER PARTICULATE CONTAMINATION OF THE BLOOD AND THE BODY AND FEAR OF METALLIC AND OTHER PARTICULATE CONTAMINATION OF THE BLOOD AND THE BODY, EXACERBATION OF UNDERLYING HIP JOINT DISORDERS, INTERNAL SCARRING AND IRRITATION AND INJURY TO THE TENDONS, LIGAMENTS, MUSCLES, BLOOD VESSELS, CARTILAGES, NERVES, BONES, AND SOFT TISSUES OF THE HIP JOINT AND SURROUNDING AREAS. UPDATE: (B)(6) 2011: PLAINTIFFS PRELIMINARY DISCLOSURE FORM WAS RECEIVED WHICH IDENTIFIED PART/LOT INFORMATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
281969 ASR UNI FEMORAL IMPL SIZE 49 TOTAL HIP IMPLANT KWA DEPUY INTERNATIONAL 2475076

Patients

Seq Age Sex Outcome Treatment
1 Other